Baker McKenzie Switzerland advised Swiss gardening and landscaping specialist B+G Schweiz on the acquisition of Giammarino & Fils, a family business based in the region of Lausanne. The Baker McKenzie team M&A
Tags :Baker McKenzie
Baker McKenzie advised the majority shareholders of the Citieffe Group, including private equity firm Archimed, on the sale of their entire stake in Medistream – a Swiss company that owns Italian medical device manufacturer Citieffe SRL
Baker McKenzie advised Mesirow, an, employee-owned financial services firm with headquarters in Chicago, on the establishment of a new office location in Geneva. The opening in question bolsters the partnership with Swiss-based Perreard Partners Investment (
Baker McKenzie Switzerland advised Swiss washing technology group Schulthess Maschinen in connection with the financing for its acquisition of Armstrong France, a company active in the sale, rental and servicing of laundry equipment in France.
Baker McKenzie Switzerland – with support by lawyers from the Firm’s Amsterdam, Paris and Singapore offices – advised Carbogen Amcis on the refinancing and enhancement of its credit facilities. A banking syndicate guided by UBS Switzerland
Baker McKenzie Switzerland advised Gétaz-Miauton, a Blackstone Group company, on the sale of the Usiniers Site in Bulle (FR) to Orllati Real Estate, via a sale-and-leaseback transaction. The site in question will host the
Swiss-based Mageba Group completed a refinancing operation via a syndicated loan with a banking consortium led by UBS Switzerland. In connection with the deal, Niederer Kraft Frey (NKF) advised UBS Switzerland, as well as the
Çalık Enerji San. ve Tic. A.Ş and its Swiss subsidiary, Calik Enerji Swiss concluded a PLN 1.166 billion guarantee facility agreement with Commerzbank Aktiengesellschaft, Zurich Branch. In connection with the operation, Baker McKenzie Switzerland advised
Landis+Gyr divested its EMEA business to private equity investor Aurelius, for an enterprise value of USD 215 m. The divestment encompasses five production sites across EMEA and involves a workforce of approximately 2,700 employees. In connection
Baker McKenzie advised Swiss medical regeneration technologies specialist Geistlich Pharma (Geistlich) on its acquisition of a minority stake in TRI Dental Implants (TRI), a provider of digital implant solutions which developed an abutment-free dental implant
